Annual FCF
$5.64 M
-$738.80 K-11.58%
December 31, 2023
Summary
- As of March 6, 2025, CPIX annual free cash flow is $5.64 million, with the most recent change of -$738.80 thousand (-11.58%) on December 31, 2023.
- During the last 3 years, CPIX annual FCF has risen by +$2.34 million (+70.88%).
- CPIX annual FCF is now -33.35% below its all-time high of $8.46 million, reached on December 31, 2007.
Performance
CPIX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$427.60 K
+$1.33 M+147.38%
September 30, 2024
Summary
- As of March 6, 2025, CPIX quarterly free cash flow is $427.60 thousand, with the most recent change of +$1.33 million (+147.38%) on September 30, 2024.
- Over the past year, CPIX quarterly FCF has stayed the same.
- CPIX quarterly FCF is now -91.68% below its all-time high of $5.14 million, reached on June 30, 2023.
Performance
CPIX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$1.72 M
-$713.90 K-71.22%
September 30, 2024
Summary
- As of March 6, 2025, CPIX TTM free cash flow is -$1.72 million, with the most recent change of -$713.90 thousand (-71.22%) on September 30, 2024.
- Over the past year, CPIX TTM FCF has stayed the same.
- CPIX TTM FCF is now -117.60% below its all-time high of $9.75 million, reached on March 31, 2012.
Performance
CPIX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CPIX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.6% | 0.0% | 0.0% |
| 3 y3 years | +70.9% | +303.3% | -136.1% |
| 5 y5 years | +585.3% | -14.9% | -184.2% |
CPIX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | at low | -91.7% | +119.5% | -121.6% | at low |
| 5 y | 5-year | -11.6% | +176.9% | -91.7% | +119.5% | -121.6% | at low |
| alltime | all time | -33.4% | +182.8% | -91.7% | +106.0% | -117.6% | +75.4% |
Cumberland Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $427.60 K(-147.4%) | -$1.72 M(+71.2%) |
| Jun 2024 | - | -$902.50 K(-58.9%) | -$1.00 M(-119.9%) |
| Mar 2024 | - | -$2.19 M(-330.2%) | $5.04 M(-10.7%) |
| Dec 2023 | $5.64 M(-11.6%) | $953.40 K(-16.5%) | $5.64 M(-15.6%) |
| Sep 2023 | - | $1.14 M(-77.8%) | $6.68 M(-16.0%) |
| Jun 2023 | - | $5.14 M(-422.6%) | $7.96 M(+59.9%) |
| Mar 2023 | - | -$1.59 M(-179.7%) | $4.98 M(-21.9%) |
| Dec 2022 | $6.38 M(+6.5%) | $2.00 M(-17.4%) | $6.38 M(+1.9%) |
| Sep 2022 | - | $2.42 M(+12.0%) | $6.26 M(+72.3%) |
| Jun 2022 | - | $2.16 M(-1221.6%) | $3.64 M(-11.9%) |
| Mar 2022 | - | -$192.40 K(-110.2%) | $4.13 M(-31.1%) |
| Dec 2021 | $5.99 M(+81.4%) | $1.88 M(-994.1%) | $5.99 M(+26.1%) |
| Sep 2021 | - | -$210.30 K(-107.9%) | $4.75 M(+1.3%) |
| Jun 2021 | - | $2.65 M(+59.0%) | $4.69 M(+0.8%) |
| Mar 2021 | - | $1.67 M(+159.4%) | $4.65 M(+40.9%) |
| Dec 2020 | $3.30 M(+62.0%) | $642.70 K(-335.8%) | $3.30 M(+4.4%) |
| Sep 2020 | - | -$272.60 K(-110.4%) | $3.16 M(-20.7%) |
| Jun 2020 | - | $2.61 M(+723.5%) | $3.99 M(+27.3%) |
| Mar 2020 | - | $317.40 K(-36.8%) | $3.13 M(+53.7%) |
| Dec 2019 | $2.04 M(-275.3%) | $502.30 K(-9.3%) | $2.04 M(-20.6%) |
| Sep 2019 | - | $554.10 K(-68.5%) | $2.57 M(-627.8%) |
| Jun 2019 | - | $1.76 M(-326.3%) | -$486.30 K(-68.6%) |
| Mar 2019 | - | -$776.90 K(-175.3%) | -$1.55 M(+33.1%) |
| Dec 2018 | -$1.16 M(-43.2%) | $1.03 M(-141.3%) | -$1.16 M(-62.8%) |
| Sep 2018 | - | -$2.50 M(-458.5%) | -$3.13 M(-1371.0%) |
| Jun 2018 | - | $697.10 K(-277.7%) | $246.10 K(-107.5%) |
| Mar 2018 | - | -$392.20 K(-58.0%) | -$3.30 M(+61.3%) |
| Dec 2017 | -$2.05 M(+31.1%) | -$934.10 K(-206.7%) | -$2.05 M(+165.4%) |
| Sep 2017 | - | $875.30 K(-130.7%) | -$771.30 K(-58.5%) |
| Jun 2017 | - | -$2.85 M(-430.8%) | -$1.86 M(+209.3%) |
| Mar 2017 | - | $861.50 K(+152.3%) | -$600.70 K(-61.5%) |
| Dec 2016 | -$1.56 M(-149.1%) | $341.40 K(-261.7%) | -$1.56 M(+97.7%) |
| Sep 2016 | - | -$211.10 K(-86.7%) | -$789.90 K(-459.2%) |
| Jun 2016 | - | -$1.59 M(+1500.5%) | $219.90 K(-93.2%) |
| Mar 2016 | - | -$99.50 K(-108.9%) | $3.22 M(+1.2%) |
| Dec 2015 | $3.18 M | $1.11 M(+39.4%) | $3.18 M(-3.8%) |
| Sep 2015 | - | $798.70 K(-43.1%) | $3.30 M(-9.6%) |
| Jun 2015 | - | $1.40 M(-1122.4%) | $3.66 M(+34.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$137.20 K(-111.1%) | $2.73 M(-20.5%) |
| Dec 2014 | $3.43 M(-150.3%) | $1.24 M(+7.6%) | $3.43 M(-219.5%) |
| Sep 2014 | - | $1.15 M(+142.9%) | -$2.87 M(-49.4%) |
| Jun 2014 | - | $474.00 K(-16.0%) | -$5.67 M(-17.8%) |
| Mar 2014 | - | $564.00 K(-111.1%) | -$6.90 M(+1.2%) |
| Dec 2013 | -$6.81 M(-248.2%) | -$5.06 M(+207.1%) | -$6.81 M(+1654.7%) |
| Sep 2013 | - | -$1.65 M(+118.2%) | -$388.30 K(-120.0%) |
| Jun 2013 | - | -$755.20 K(-216.4%) | $1.95 M(-31.8%) |
| Mar 2013 | - | $648.70 K(-52.5%) | $2.85 M(-38.0%) |
| Dec 2012 | $4.60 M(-44.5%) | $1.37 M(+99.1%) | $4.60 M(+9.3%) |
| Sep 2012 | - | $685.80 K(+357.8%) | $4.21 M(-30.4%) |
| Jun 2012 | - | $149.80 K(-93.8%) | $6.05 M(-38.0%) |
| Mar 2012 | - | $2.40 M(+146.0%) | $9.75 M(+17.7%) |
| Dec 2011 | $8.28 M(-2063.1%) | $974.60 K(-61.4%) | $8.28 M(+31.5%) |
| Sep 2011 | - | $2.53 M(-34.4%) | $6.30 M(+65.2%) |
| Jun 2011 | - | $3.85 M(+314.6%) | $3.81 M(+7232.7%) |
| Mar 2011 | - | $929.40 K(-191.9%) | $52.00 K(-112.3%) |
| Dec 2010 | -$422.00 K(+37.3%) | -$1.01 M(-2532.0%) | -$422.00 K(-69.2%) |
| Sep 2010 | - | $41.60 K(-55.1%) | -$1.37 M(+51.1%) |
| Jun 2010 | - | $92.70 K(-79.6%) | -$907.50 K(-147.4%) |
| Mar 2010 | - | $455.40 K(-123.2%) | $1.92 M(-723.0%) |
| Dec 2009 | -$307.40 K(-104.9%) | -$1.96 M(-488.3%) | -$307.40 K(-108.1%) |
| Sep 2009 | - | $504.90 K(-82.7%) | $3.80 M(-17.5%) |
| Jun 2009 | - | $2.92 M(-265.0%) | $4.61 M(+72.4%) |
| Mar 2009 | - | -$1.77 M(-182.3%) | $2.67 M(-57.3%) |
| Dec 2008 | $6.26 M(-26.0%) | $2.15 M(+63.9%) | $6.26 M(-6.7%) |
| Sep 2008 | - | $1.31 M(+33.4%) | $6.71 M(-1.7%) |
| Jun 2008 | - | $982.10 K(-46.1%) | $6.83 M(-2.4%) |
| Mar 2008 | - | $1.82 M(-29.8%) | $7.00 M(-17.2%) |
| Dec 2007 | $8.46 M(-292.8%) | $2.60 M(+81.8%) | $8.46 M(+9.5%) |
| Sep 2007 | - | $1.43 M(+24.0%) | $7.73 M(+9.9%) |
| Jun 2007 | - | $1.15 M(-64.9%) | $7.03 M(-662.6%) |
| Mar 2007 | - | $3.28 M(+75.8%) | -$1.25 M(-71.5%) |
| Dec 2006 | -$4.39 M(-309.3%) | $1.87 M(+155.9%) | -$4.39 M(-29.8%) |
| Sep 2006 | - | $729.70 K(-110.2%) | -$6.26 M(-10.4%) |
| Jun 2006 | - | -$7.13 M(-5082.3%) | -$6.99 M(-4982.3%) |
| Mar 2006 | - | $143.10 K | $143.10 K |
| Dec 2005 | $2.10 M | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual FCF year-on-year change?
- What is Cumberland Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly FCF year-on-year change?
- What is Cumberland Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM FCF year-on-year change?
What is Cumberland Pharmaceuticals annual free cash flow?
The current annual FCF of CPIX is $5.64 M
What is the all time high annual FCF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual free cash flow is $8.46 M
What is Cumberland Pharmaceuticals annual FCF year-on-year change?
Over the past year, CPIX annual free cash flow has changed by -$738.80 K (-11.58%)
What is Cumberland Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of CPIX is $427.60 K
What is the all time high quarterly FCF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly free cash flow is $5.14 M
What is Cumberland Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, CPIX quarterly free cash flow has changed by $0.00 (0.00%)
What is Cumberland Pharmaceuticals TTM free cash flow?
The current TTM FCF of CPIX is -$1.72 M
What is the all time high TTM FCF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM free cash flow is $9.75 M
What is Cumberland Pharmaceuticals TTM FCF year-on-year change?
Over the past year, CPIX TTM free cash flow has changed by $0.00 (0.00%)